Epertinib hydrochloride
Epertinib hydrochloride is a potent, orally bioavailable, and selective reversible inhibitor of EGFR, HER2, and HER4 tyrosine kinases. It demonstrates significant antitumor activity in preclinical research, including in vitro cell-based assays and in vivo xenograft models, particularly for cancers driven by these receptors.
Product Specifications
CAS Number
2071195-74-7
Product Name Alternative
Inhibit, Epidermal growth factor receptor, Epertinib, Epertinib Hydrochloride, Epertinib hydrochloride, EGFR, ErbB-1, Inhibitor, HER4, HER2, HER1, S 22611, S 22611 Hydrochloride, S-22611, S22611 Hydrochloride, S-22611 hydrochloride, S-22611 Hydrochloride, S22611
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.14% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (6.71 mM) ; DMSO:125 mg/mL (209.56 mM)
Smiles
Cl.CC#C\C (=N/OC[C@H]1COCCN1) c1ccc2ncnc (Nc3ccc (OCc4cccc (F) c4) c (Cl) c3) c2c1
Molecular Formula
C30H28Cl2FN5O3
Molecular Weight
596.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
